A multiple therapy hypothesis for treatment of COVID-19 patients

Area of Science:

• Respiratory medicine
• Infectious diseases
• Biotechnology

Background:

• COVID-19 pandemic caused by SARS-CoV-2 has led to significant mortality.
• Current treatments targeting specific viral proteins may face challenges with evolving strains.
• A multi-faceted therapeutic strategy is crucial for managing the pandemic.

Purpose of the Study:

• To propose a novel combination therapy for COVID-19.
• To investigate the potential of cool air therapy (CAT) and purified air technology (PAT) in an oxygen species cool air respirator (OSCAR).
• To reduce viral load and illness severity in COVID-19 patients.

Main Methods:

• The proposed therapy involves a combination of CAT and PAT delivered via OSCAR.
• This approach utilizes a general physical and chemical mechanism.
• Individual dose-response relationships are considered for personalized treatment.

Main Results:

• The CAT + PAT in OSCAR therapy is hypothesized to reduce SARS-CoV-2 viral load.
• The proposed method is expected to decrease the severity of illness in COVID-19 patients.
• This therapy is anticipated to work synergistically with existing treatments like vaccines and antivirals.

Conclusions:

• A combination of CAT and PAT in OSCAR offers a promising physical and chemical therapeutic approach for COVID-19.
• This novel therapy could serve as a safe and effective adjunct to treatments targeting specific viral proteins.
• The proposed multi-therapy strategy holds potential for controlling the COVID-19 pandemic.